Biology:Lipopolysaccharide

From HandWiki
Short description: Class of molecules found in the outer membrane of Gram-negative bacteria
Structure of a lipopolysaccharide (LPS)

Lipopolysaccharides (LPS) are large molecules consisting of a lipid and a polysaccharide that are bacterial toxins. They are composed of an O-antigen, an outer core, and an inner core all joined by covalent bonds, and are found in the bacterial capsule, the outermost membrane of cell envelope of Gram-negative bacteria, such as E. coli and Salmonella.[1] Today, the term endotoxin is often used synonymously with LPS,[2] although there are a few endotoxins (in the original sense of toxins that are inside the bacterial cell that are released when the cell disintegrates) that are not related to LPS, such as the so-called delta endotoxin proteins produced by Bacillus thuringiensis.[3]

Lipopolysaccharides can have substantial impacts on human health, primarily through interactions with the immune system. LPS is a potent activator of the immune system and pyrogen (agent that causes fever).[4] In severe cases, LPS can play a role in causing septic shock.[5] In lower levels and over a longer time period, there is evidence LPS may play an important and harmful role in autoimmunity, obesity, depression, and cellular senescence.[6][7][8][9]

Discovery

The toxic activity of LPS was first discovered and termed endotoxin by Richard Friedrich Johannes Pfeiffer. He distinguished between exotoxins, toxins that are released by bacteria into the surrounding environment, and endotoxins, which are toxins "within" the bacterial cell and released only after destruction of the bacterial outer membrane.[10] Subsequent work showed that release of LPS from gram negative microbes does not necessarily require the destruction of the bacterial cell wall, but rather, LPS is secreted as part of the normal physiological activity of membrane vesicle trafficking in the form of bacterial outer membrane vesicles (OMVs), which may also contain other virulence factors and proteins.[11][1]

Functions in bacteria

LPS is a major component of the outer membrane of Gram-negative bacteria, contributing greatly to the structural integrity of the bacteria and protecting the membrane from certain kinds of chemical attack. LPS is the most abundant antigen on the cell surface of most Gram-negative bacteria, contributing up to 80% of the outer membrane of E. coli and Salmonella.[1] LPS increases the negative charge of the cell membrane and helps stabilize the overall membrane structure. It is of crucial importance to many Gram-negative bacteria, which die if the genes coding for it are mutated or removed. However, it appears that LPS is nonessential in at least some Gram-negative bacteria, such as Neisseria meningitidis, Moraxella catarrhalis, and Acinetobacter baumannii.[12] It has also been implicated in non-pathogenic aspects of bacterial ecology, including surface adhesion, bacteriophage sensitivity, and interactions with predators such as amoebae. LPS is also required for the functioning of omptins, a class of bacterial protease.[13]

Composition

The saccharolipid Kdo2-Lipid A. Kdo residues in red (core), glucosamine residues in blue, acyl chains in black and phosphate groups in green.

Lipopolysaccharides are composed of three parts: The O antigen (or O polysaccharide), the Core oligosaccharide, and Lipid A.

O-antigen

The repetitive glycan polymer contained within an LPS is referred to as the O antigen, O polysaccharide, or O side-chain of the bacteria. The O antigen is attached to the core oligosaccharide, and comprises the outermost domain of the LPS molecule. The composition of the O chain varies from strain to strain; there are over 160 different O antigen structures produced by different E. coli strains.[14] The presence or absence of O chains determines whether the LPS is considered "rough" or "smooth". Full-length O-chains would render the LPS smooth, whereas the absence or reduction of O-chains would make the LPS rough.[15] Bacteria with rough LPS usually have more penetrable cell membranes to hydrophobic antibiotics, since a rough LPS is more hydrophobic.[16] O antigen is exposed on the very outer surface of the bacterial cell, and, as a consequence, is a target for recognition by host antibodies.

Core

Main page: Biology:Core oligosaccharide

The core domain always contains an oligosaccharide component that attaches directly to lipid A and commonly contains sugars such as heptose and 3-Deoxy-D-manno-oct-2-ulosonic acid (also known as KDO, keto-deoxyoctulosonate).[17] The LPS cores of many bacteria also contain non-carbohydrate components, such as phosphate, amino acids, and ethanolamine substituents.

Lipid A

Main page: Biology:Lipid A

Lipid A is, in normal circumstances, a phosphorylated glucosamine disaccharide decorated with multiple fatty acids. These hydrophobic fatty acid chains anchor the LPS into the bacterial membrane, and the rest of the LPS projects from the cell surface. The lipid A domain is responsible for much of the toxicity of Gram-negative bacteria. When bacterial cells are lysed by the immune system, fragments of membrane containing lipid A are released into the circulation, causing fever, diarrhea, and possible fatal endotoxic shock (also called septic shock). The Lipid A moiety is a very conserved component of the LPS.[18] However Lipid A structure varies among bacterial species. Lipid A structure largely defines the degree and nature of the overall host immune activation.[19]

Lipooligosaccharides

The "rough form" of LPS has a lower molecular weight due to the absence of the O polysaccharide. In its place is a short oligosaccharide: this form is known as Lipooligosaccharide (LOS), and is a glycolipid found in the outer membrane of some types of Gram-negative bacteria, such as Neisseria spp. and Haemophilus spp.[6][20] LOS plays a central role in maintaining the integrity and functionality of the outer membrane of the Gram negative cell envelope. LOS play an important role in the pathogenesis of certain bacterial infections because they are capable of acting as immunostimulators and immunomodulators.[6] Furthermore, LOS molecules are responsible for the ability of some bacterial strains to display molecular mimicry and antigenic diversity, aiding in the evasion of host immune defenses and thus contributing to the virulence of these bacterial strains. In the case of Neisseria meningitidis, the lipid A portion of the molecule has a symmetrical structure and the inner core is composed of 3-deoxy-D-manno-2-octulosonic acid (KDO) and heptose (Hep) moieties. The outer core oligosaccharide chain varies depending on the bacterial strain.[6][20]

LPS detoxification

A highly conserved host enzyme called acyloxyacyl hydrolase (AOAH) may detoxify LPS when it enters, or is produced in, animal tissues. It may also convert LPS in the intestine into an LPS inhibitor. Neutrophils, macrophages and dendritic cells produce this lipase, which inactivates LPS by removing the two secondary acyl chains from lipid A to produce tetraacyl LPS. If mice are given LPS parenterally, those that lack AOAH develop high titers of non-specific antibodies, develop prolonged hepatomegaly, and experience prolonged endotoxin tolerance. LPS inactivation may be required for animals to restore homeostasis after parenteral LPS exposure.[21] Although mice have many other mechanisms for inhibiting LPS signaling, none is able to prevent these changes in animals that lack AOAH.

Dephosphorylation of LPS by intestinal alkaline phosphatase can reduce the severity of Salmonella tryphimurium and Clostridioides difficile infection restoring normal gut microbiota.[22] Alkaline phosphatase prevents intestinal inflammation (and "leaky gut") from bacteria by dephosphorylating the Lipid A portion of LPS.[23][24][25]

Biosynthesis and transport

LPS final assembly: O-antigen subunits are translocated across the inner membrane (by Wzx) where they are polymerized (by Wzy, chain length determined by Wzz) and ligated (by WaaL) on to complete Core-Lipid A molecules (which were translocated by MsbA).[26]

thumb|left|380px|LPS transport: Completed LPS molecules are transported across the [[periplasm and outer membrane by the lipopolysaccharide transport (Lpt) proteins A, B, C, D, E, F, and G.[27]]]

The entire process of making LPS starts with a molecule called lipid A-Kdo2, which is first created on the surface of the bacterial cell's inner membrane. Then, additional sugars are added to this molecule on the inner membrane before it's moved to the space between the inner and outer membranes (periplasmic space) with the help of a protein called MsbA. The O-antigen, another part of LPS, is made by special enzyme complexes on the inner membrane. It is then moved to the outer membrane through three different systems: one is Wzy-dependent, another relies on ABC transporters, and the third involves a synthase-dependent process.[28]

Ultimately, LPS is transported to the outer membrane by a membrane-to-membrane bridge of lipolysaccharide transport (Lpt) proteins.[27][29] This transporter is a potential antibiotic target.[30][31]

Biological effects on hosts infected with Gram-negative bacteria

Immune response

LPS acts as the prototypical endotoxin because it binds the CD14/TLR4/MD2 receptor complex in many cell types, but especially in monocytes, dendritic cells, macrophages and B cells, which promotes the secretion of pro-inflammatory cytokines, nitric oxide, and eicosanoids.[32] Bruce Beutler was awarded a portion of the 2011 Nobel Prize in Physiology or Medicine for his work demonstrating that TLR4 is the LPS receptor.[33][34]

As part of the cellular stress response, superoxide is one of the major reactive oxygen species induced by LPS in various cell types that express TLR (toll-like receptor).[35] LPS is also an exogenous pyrogen (fever-inducing substance).[4]

LPS function has been under experimental research for several years due to its role in activating many transcription factors. LPS also produces many types of mediators involved in septic shock. Humans are much more sensitive to LPS than other animals (e.g., mice). A dose of 1 µg/kg induces shock in humans, but mice will tolerate a dose up to a thousand times higher.[36] This may relate to differences in the level of circulating natural antibodies between the two species.[37][38] Said et al. showed that LPS causes an IL-10-dependent inhibition of CD4 T-cell expansion and function by up-regulating PD-1 levels on monocytes which leads to IL-10 production by monocytes after binding of PD-1 by PD-L1.[39]

Endotoxins are in large part responsible for the dramatic clinical manifestations of infections with pathogenic Gram-negative bacteria, such as Neisseria meningitidis, the pathogens that causes meningococcal disease, including meningococcemia, Waterhouse–Friderichsen syndrome, and meningitis.

Portions of the LPS from several bacterial strains have been shown to be chemically similar to human host cell surface molecules; the ability of some bacteria to present molecules on their surface which are chemically identical or similar to the surface molecules of some types of host cells is termed molecular mimicry.[40] For example, in Neisseria meningitidis L2,3,5,7,9, the terminal tetrasaccharide portion of the oligosaccharide (lacto-N-neotetraose) is the same tetrasaccharide as that found in paragloboside, a precursor for ABH glycolipid antigens found on human erythrocytes.[6] In another example, the terminal trisaccharide portion (lactotriaose) of the oligosaccharide from pathogenic Neisseria spp. LOS is also found in lactoneoseries glycosphingolipids from human cells.[6] Most meningococci from groups B and C, as well as gonococci, have been shown to have this trisaccharide as part of their LOS structure.[6] The presence of these human cell surface 'mimics' may, in addition to acting as a 'camouflage' from the immune system, play a role in the abolishment of immune tolerance when infecting hosts with certain human leukocyte antigen (HLA) genotypes, such as HLA-B35.[6]

LPS can be sensed directly by hematopoietic stem cells (HSCs) through the bonding with TLR4, causing them to proliferate in reaction to a systemic infection. This response activate the TLR4-TRIF-ROS-p38 signaling within the HSCs and through a sustained TLR4 activation can cause a proliferative stress, leading to impair their competitive repopulating ability.[41] Infection in mice using S. typhimurium showed similar results, validating the experimental model also in vivo.

Effect of variability on immune response

Toll-like receptors of the innate immune system recognize LPS and trigger an immune response.

O-antigens (the outer carbohydrates) are the most variable portion of the LPS molecule, imparting antigenic specificity. In contrast, lipid A is the most conserved part. However, lipid A composition also may vary (e.g., in number and nature of acyl chains even within or between genera). Some of these variations may impart antagonistic properties to these LPS. For example, diphosphoryl lipid A of Rhodobacter sphaeroides (RsDPLA) is a potent antagonist of LPS in human cells, but is an agonist in hamster and equine cells.[42]

It has been speculated that conical lipid A (e.g., from E. coli) is more agonistic, while less conical lipid A like that of Porphyromonas gingivalis may activate a different signal (TLR2 instead of TLR4), and completely cylindrical lipid A like that of Rhodobacter sphaeroides is antagonistic to TLRs.[43][44] In general, LPS gene clusters are highly variable between different strains, subspecies, species of bacterial pathogens of plants and animals.[45][46]

Normal human blood serum contains anti-LOS antibodies that are bactericidal and patients that have infections caused by serotypically distinct strains possess anti-LOS antibodies that differ in their specificity compared with normal serum.[47] These differences in humoral immune response to different LOS types can be attributed to the structure of the LOS molecule, primarily within the structure of the oligosaccharide portion of the LOS molecule.[47] In Neisseria gonorrhoeae it has been demonstrated that the antigenicity of LOS molecules can change during an infection due to the ability of these bacteria to synthesize more than one type of LOS,[47] a characteristic known as phase variation. Additionally, Neisseria gonorrhoeae, as well as Neisseria meningitidis and Haemophilus influenzae,[6] are capable of further modifying their LOS in vitro, for example through sialylation (modification with sialic acid residues), and as a result are able to increase their resistance to complement-mediated killing [47] or even down-regulate complement activation[6] or evade the effects of bactericidal antibodies.[6] Sialylation may also contribute to hindered neutrophil attachment and phagocytosis by immune system cells as well as a reduced oxidative burst.[6] Haemophilus somnus, a pathogen of cattle, has also been shown to display LOS phase variation, a characteristic which may help in the evasion of bovine host immune defenses.[48] Taken together, these observations suggest that variations in bacterial surface molecules such as LOS can help the pathogen evade both the humoral (antibody and complement-mediated) and the cell-mediated (killing by neutrophils, for example) host immune defenses.

Non-canonical pathways of LPS recognition

Recently, it was shown that in addition to TLR4 mediated pathways, certain members of the family of the transient receptor potential ion channels recognize LPS.[49] LPS-mediated activation of TRPA1 was shown in mice[50] and Drosophila melanogaster flies.[51] At higher concentrations, LPS activates other members of the sensory TRP channel family as well, such as TRPV1, TRPM3 and to some extent TRPM8.[52] LPS is recognized by TRPV4 on epithelial cells. TRPV4 activation by LPS was necessary and sufficient to induce nitric oxide production with a bactericidal effect.[53]

Testing

Lipopolysaccharide is a significant factor that makes bacteria harmful, and it helps categorize them into different groups based on their structure and function. This makes LPS a useful marker for telling apart various Gram-negative bacteria. Swiftly identifying and understanding the types of pathogens involved is crucial for promptly managing and treating infections. Since LPS is the main trigger for the immune response in our cells, it acts as an early signal of an acute infection. Therefore, LPS testing is more specific and meaningful than many other serological tests.[54]

The current methods for testing LPS are quite sensitive, but many of them struggle to differentiate between different LPS groups. Additionally, the nature of LPS, which has both water-attracting and water-repelling properties (amphiphilic), makes it challenging to develop sensitive and user-friendly tests.[54]

The typical detection methods rely on identifying the lipid A part of LPS. However, this method has limitations because Lipid A is very similar among different bacterial species and serotypes. LPS testing techniques fall into six categories, and they often overlap: in vivo tests, in vitro tests, modified immunoassays, biological assays, and chemical assays.[54]

Pathophysiology

LPS is a powerful toxin that, when in the body, triggers inflammation by binding to cell receptors. Excessive LPS in the blood can lead to endotoxemia, potentially causing a harmful condition called septic shock. This condition includes symptoms like rapid heart rate, quick breathing, temperature changes, and blood clotting issues, resulting in blood vessels widening and reduced blood volume, leading to cellular dysfunction.[54]

Recent research indicates that even small LPS exposure is associated with autoimmune diseases and allergies. High levels of LPS in the blood can lead to metabolic syndrome, increasing the risk of conditions like diabetes, heart disease, and liver problems.[54]

LPS also plays a crucial role in symptoms caused by infections from harmful bacteria, including severe conditions like Waterhouse-Friderichsen syndrome, meningococcemia, and meningitis. Certain bacteria can adapt their LPS to cause long-lasting infections in the respiratory and digestive systems.[54]

Recent studies have shown that LPS disrupts cell membrane lipids, affecting cholesterol and metabolism, potentially leading to high cholesterol, abnormal blood lipid levels, and non-alcoholic fatty liver disease. In some cases, LPS can interfere with toxin clearance, which may be linked to neurological issues.[54]

Health effects

In general the health effects of LPS are due to its abilities as a potent activator and modulator of the immune system, especially its inducement of inflammation.

Endotoxemia

The presence of endotoxins in the blood is called endotoxemia. High level of endotoxemia can lead to septic shock,[55] while lower concentration of endotoxins in the bloodstream is called metabolic endotoxemia.[56] Endotoxemia is associated with obesity, diet,[57] cardiovascular diseases,[57] and diabetes,[56] while also host genetics might have an effect.[58]

Moreover, endotoxemia of intestinal origin, especially, at the host-pathogen interface, is considered to be an important factor in the development of alcoholic hepatitis,[59] which is likely to develop on the basis of the small bowel bacterial overgrowth syndrome and an increased intestinal permeability.[60]

Lipid A may cause uncontrolled activation of mammalian immune systems with production of inflammatory mediators that may lead to septic shock.[20] This inflammatory reaction is mediated by Toll-like receptor 4 which is responsible for immune system cell activation.[20] Damage to the endothelial layer of blood vessels caused by these inflammatory mediators can lead to capillary leak syndrome, dilation of blood vessels and a decrease in cardiac function and can lead to septic shock.[61] Pronounced complement activation can also be observed later in the course as the bacteria multiply in the blood.[61] High bacterial proliferation triggering destructive endothelial damage can also lead to disseminated intravascular coagulation (DIC) with loss of function of certain internal organs such as the kidneys, adrenal glands and lungs due to compromised blood supply. The skin can show the effects of vascular damage often coupled with depletion of coagulation factors in the form of petechiae, purpura and ecchymoses. The limbs can also be affected, sometimes with devastating consequences such as the development of gangrene, requiring subsequent amputation.[61] Loss of function of the adrenal glands can cause adrenal insufficiency and additional hemorrhage into the adrenals causes Waterhouse-Friderichsen syndrome, both of which can be life-threatening.

It has also been reported that gonococcal LOS can cause damage to human fallopian tubes.[47]

Auto-immune disease

The molecular mimicry of some LOS molecules is thought to cause autoimmune-based host responses, such as flareups of multiple sclerosis.[6][40] Other examples of bacterial mimicry of host structures via LOS are found with the bacteria Helicobacter pylori and Campylobacter jejuni, organisms which cause gastrointestinal disease in humans, and Haemophilus ducreyi which causes chancroid. Certain C. jejuni LPS serotypes (attributed to certain tetra- and pentasaccharide moieties of the core oligosaccharide) have also been implicated with Guillain–Barré syndrome and a variant of Guillain–Barré called Miller-Fisher syndrome.[6]

Link to obesity

Epidemiological studies have shown that increased endotoxin load, which can be a result of increased populations of endotoxin-producing bacteria in the intestinal tract, is associated with certain obesity-related patient groups.[7][62][63] Other studies have shown that purified endotoxin from Escherichia coli can induce obesity and insulin-resistance when injected into germ-free mouse models.[64] A more recent study has uncovered a potentially contributing role for Enterobacter cloacae B29 toward obesity and insulin resistance in a human patient.[65] The presumed mechanism for the association of endotoxin with obesity is that endotoxin induces an inflammation-mediated pathway accounting for the observed obesity and insulin resistance.[64] Bacterial genera associated with endotoxin-related obesity effects include Escherichia and Enterobacter.

Depression

There is experimental and observational evidence that LPS might play a role in depression. Administration of LPS in mice can lead to depressive symptoms, and there seem to be elevated levels of LPS in some people with depression. Inflammation may sometimes play a role in the development of depression, and LPS is pro-inflammatory.[8]

Cellular senescence

Inflammation induced by LPS can induce cellular senescence, as has been shown for the lung epithelial cells and microglial cells (the latter leading to neurodegeneration).[9]

Role as contaminant in biotechnology and research

Lipopolysaccharides are frequent contaminants in plasmid DNA prepared from bacteria or proteins expressed from bacteria, and must be removed from the DNA or protein to avoid contaminating experiments and to avoid toxicity of products manufactured using industrial fermentation.[66]

Ovalbumin is frequently contaminated with endotoxins. Ovalbumin is one of the extensively studied proteins in animal models and also an established model allergen for airway hyper-responsiveness (AHR). Commercially available ovalbumin that is contaminated with LPS can falsify research results, as it does not accurately reflect the effect of the protein antigen on animal physiology.[67]

In pharmaceutical production, it is necessary to remove all traces of endotoxin from drug product containers, as even small amounts of endotoxin will cause illness in humans. A depyrogenation oven is used for this purpose. Temperatures in excess of 300 °C are required to fully break down LPS.[68]

The standard assay for detecting presence of endotoxin is the Limulus Amebocyte Lysate (LAL) assay, utilizing blood from the Horseshoe crab (Limulus polyphemus).[69] Very low levels of LPS can cause coagulation of the limulus lysate due to a powerful amplification through an enzymatic cascade. However, due to the dwindling population of horseshoe crabs, and the fact that there are factors that interfere with the LAL assay, efforts have been made to develop alternative assays, with the most promising ones being ELISA tests using a recombinant version of a protein in the LAL assay, Factor C.[70]

Testing
Lipopolysaccharide, is a significant factor that makes bacteria harmful, and it helps categorize them into different groups based on their structure and function. This makes LPS a useful marker for telling apart various Gram-negative bacteria. Swiftly identifying and understanding the types of pathogens involved is crucial for promptly managing and treating infections. Since LPS is the main trigger for the immune response in our cells, it acts as an early signal of an acute infection. Therefore, LPS testing is more specific and meaningful than many other serological tests. The current methods for testing LPS are quite sensitive, but many of them struggle to differentiate between different LPS groups. Additionally, the nature of LPS, which has both water-attracting and water-repelling properties (amphiphilic), makes it challenging to develop sensitive and user-friendly tests. The typical detection methods rely on identifying the lipid A part of LPS. However, this method has limitations because Lipid A is very similar among different bacterial species and serotypes. LPS testing techniques fall into six categories, and they often overlap: in vivo tests, in vitro tests, modified immunoassays, biological assays, and chemical assays. [54]
Pathophysiology
LPS is a powerful toxin that, when in the body, triggers inflammation by binding to cell receptors. Excessive LPS in the blood can lead to endotoxemia, potentially causing a harmful condition called septic shock. This condition includes symptoms like rapid heart rate, quick breathing, temperature changes, and blood clotting issues, resulting in blood vessels widening and reduced blood volume, leading to cellular dysfunction. Recent research indicates that even small LPS exposure is associated with autoimmune diseases and allergies. High levels of LPS in the blood can lead to metabolic syndrome, increasing the risk of conditions like diabetes, heart disease, and liver problems. LPS also plays a crucial role in symptoms caused by infections from harmful bacteria, including severe conditions like Waterhouse-Friderichsen syndrome, meningococcemia, and meningitis. Certain bacteria can adapt their LPS to cause long-lasting infections in the respiratory and digestive systems. Recent studies have shown that LPS disrupts cell membrane lipids, affecting cholesterol and metabolism, potentially leading to high cholesterol, abnormal blood lipid levels, and non-alcoholic fatty liver disease. In some cases, LPS can interfere with toxin clearance, which may be linked to neurological issues.[54]

See also

References

  1. ↑ 1.0 1.1 1.2 "Outer Membrane Vesicles of Gram-Negative Bacteria: An Outlook on Biogenesis". Frontiers in Microbiology 12: 557902. 2021. doi:10.3389/fmicb.2021.557902. PMID 33746909. 
  2. ↑ "Bacterial endotoxin: molecular relationships of structure to activity and function". FASEB Journal 8 (2): 217–225. February 1994. doi:10.1096/fasebj.8.2.8119492. PMID 8119492. 
  3. ↑ "Structural and functional analysis of a cloned delta endotoxin of Bacillus thuringiensis berliner 1715". European Journal of Biochemistry 161 (2): 273–280. December 1986. doi:10.1111/j.1432-1033.1986.tb10443.x. PMID 3023091. 
  4. ↑ 4.0 4.1 "Mechanisms of fever production and lysis: lessons from experimental LPS fever". Comprehensive Physiology 4 (4): 1563–1604. October 2014. doi:10.1002/cphy.c130033. ISBN 978-0-470-65071-4. PMID 25428854. 
  5. ↑ "Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012". Critical Care Medicine 41 (2): 580–637. February 2013. doi:10.1097/CCM.0b013e31827e83af. PMID 23353941. 
  6. ↑ 6.00 6.01 6.02 6.03 6.04 6.05 6.06 6.07 6.08 6.09 6.10 6.11 6.12 6.13 "Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease". FEMS Immunology and Medical Microbiology 16 (2): 105–115. December 1996. doi:10.1016/s0928-8244(96)00072-7. PMID 8988391. 
  7. ↑ 7.0 7.1 "Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance". International Journal of Obesity 36 (11): 1442–1449. November 2012. doi:10.1038/ijo.2011.256. PMID 22184060. 
  8. ↑ 8.0 8.1 "Comparison of bacterial lipopolysaccharide-induced sickness behavior in rodents and humans: Relevance for symptoms of anxiety and depression". Neuroscience and Biobehavioral Reviews 115: 15–24. August 2020. doi:10.1016/j.neubiorev.2020.05.001. PMID 32433924. 
  9. ↑ 9.0 9.1 "Cellular senescence: Molecular mechanisms and pathogenicity". Journal of Cellular Physiology 233 (12): 9121–9135. December 2018. doi:10.1002/jcp.26956. PMID 30078211. 
  10. ↑ Textbook of Microbiology & Immunology. India: Elsevier. 1 January 2009. ISBN 978-8131221631. https://books.google.com/books?id=HcgGLfxDJSQC. 
  11. ↑ "Biological functions and biogenesis of secreted bacterial outer membrane vesicles". Annual Review of Microbiology 64: 163–184. 2010. doi:10.1146/annurev.micro.091208.073413. PMID 20825345. 
  12. ↑ "On the essentiality of lipopolysaccharide to Gram-negative bacteria". Current Opinion in Microbiology 16 (6): 779–785. December 2013. doi:10.1016/j.mib.2013.09.007. PMID 24148302. 
  13. ↑ "The omptin family of enterobacterial surface proteases/adhesins: from housekeeping in Escherichia coli to systemic spread of Yersinia pestis". International Journal of Medical Microbiology 294 (1): 7–14. July 2004. doi:10.1016/j.ijmm.2004.01.003. PMID 15293449. 
  14. ↑ "Lipopolysaccharide endotoxins". Annual Review of Biochemistry 71: 635–700. 2002. doi:10.1146/annurev.biochem.71.110601.135414. PMID 12045108. 
  15. ↑ "Smooth and rough lipopolysaccharide phenotypes of Brucella induce different intracellular trafficking and cytokine/chemokine release in human monocytes". Journal of Leukocyte Biology 74 (6): 1045–1055. December 2003. doi:10.1189/jlb.0103015. PMID 12960272. 
  16. ↑ "Diffusion of macrolide antibiotics through the outer membrane of Moraxella catarrhalis". Journal of Infection and Chemotherapy 5 (4): 196–200. December 1999. doi:10.1007/s101560050034. PMID 11810516. 
  17. ↑ "Chemistry and metabolism of 3-deoxy-D-mannooctulosonic acid. I. Stereochemical determination". The Journal of Biological Chemistry 243 (7): 1578–1584. April 1968. doi:10.1016/S0021-9258(18)93581-7. PMID 4296687. 
  18. ↑ "Endotoxin of Neisseria meningitidis composed only of intact lipid A: inactivation of the meningococcal 3-deoxy-D-manno-octulosonic acid transferase". Journal of Bacteriology 184 (9): 2379–2388. May 2002. doi:10.1128/JB.184.9.2379-2388.2002. PMID 11948150. 
  19. ↑ "Mass Spectrometry-based Structural Analysis and Systems Immunoproteomics Strategies for Deciphering the Host Response to Endotoxin". Journal of Molecular Biology 430 (17): 2641–2660. August 2018. doi:10.1016/j.jmb.2018.06.032. PMID 29949751. 
  20. ↑ 20.0 20.1 20.2 20.3 "Structural characterization of bacterial lipopolysaccharides with mass spectrometry and on- and off-line separation techniques". Mass Spectrometry Reviews 32 (2): 90–117. 2013. doi:10.1002/mas.21352. PMID 23165926. Bibcode: 2013MSRv...32...90K. 
  21. ↑ Chapter 2 Kill the Bacteria…and Also Their Messengers?. Advances in Immunology. 103. 2009. pp. 29–48. doi:10.1016/S0065-2776(09)03002-8. ISBN 9780123748324. 
  22. ↑ "The Role of Intestinal Alkaline Phosphatase in Inflammatory Disorders of Gastrointestinal Tract". Mediators of Inflammation 2017: 9074601. 2017. doi:10.1155/2017/9074601. PMID 28316376. 
  23. ↑ "Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota". Cell Host & Microbe 2 (6): 371–382. December 2007. doi:10.1016/j.chom.2007.10.010. PMID 18078689. 
  24. ↑ "Intestinal alkaline phosphatase prevents antibiotic-induced susceptibility to enteric pathogens". Annals of Surgery 259 (4): 715–722. April 2014. doi:10.1097/sla.0b013e31828fae14. PMID 23598380. 
  25. ↑ "Intestinal alkaline phosphatase: novel functions and protective effects". Nutrition Reviews 72 (2): 82–94. February 2014. doi:10.1111/nure.12082. PMID 24506153. 
  26. ↑ "Lipopolysaccharide: Biosynthetic pathway and structure modification". Progress in Lipid Research 49 (2): 97–107. April 2010. doi:10.1016/j.plipres.2009.06.002. PMID 19815028. 
  27. ↑ 27.0 27.1 "Transport of lipopolysaccharide across the cell envelope: the long road of discovery". Nature Reviews. Microbiology 7 (9): 677–683. September 2009. doi:10.1038/nrmicro2184. PMID 19633680. 
  28. ↑ "Targeting LPS biosynthesis and transport in gram-negative bacteria in the era of multi-drug resistance". Biochimica Et Biophysica Acta. Molecular Cell Research 1870 (3): 119407. March 2023. doi:10.1016/j.bbamcr.2022.119407. PMID 36543281. 
  29. ↑ "Lipopolysaccharide is transported to the cell surface by a membrane-to-membrane protein bridge". Science 359 (6377): 798–801. February 2018. doi:10.1126/science.aar1886. PMID 29449493. 
  30. ↑ "A new antibiotic traps lipopolysaccharide in its intermembrane transporter". Nature: 1–6. January 2024. doi:10.1038/s41586-023-06799-7. 
  31. ↑ "A novel antibiotic class targeting the lipopolysaccharide transporter". Nature: 1–6. January 2024. doi:10.1038/s41586-023-06873-0. PMID 38172634. 
  32. ↑ Basic Immunology. Elsevier. 2006. ISBN 978-1-4160-2974-8. 
  33. ↑ "Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene". Science 282 (5396): 2085–2088. December 1998. doi:10.1126/science.282.5396.2085. PMID 9851930. Bibcode: 1998Sci...282.2085P. 
  34. ↑ "The 2011 Nobel Prize in Physiology or Medicine - Press Release". https://www.nobelprize.org/nobel_prizes/medicine/laureates/2011/press.html. 
  35. ↑ "Roles of Toll-Like Receptors in Nitroxidative Stress in Mammals". Cells 8 (6): 576. June 2019. doi:10.3390/cells8060576. PMID 31212769. 
  36. ↑ "Resilience to bacterial infection: difference between species could be due to proteins in serum". The Journal of Infectious Diseases 201 (2): 223–232. January 2010. doi:10.1086/649557. PMID 20001600. 
  37. ↑ "Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide". Journal of Immunology 159 (2): 970–975. July 1997. doi:10.4049/jimmunol.159.2.970. PMID 9218618. 
  38. ↑ "A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection". The Journal of Experimental Medicine 188 (12): 2381–2386. December 1998. doi:10.1084/jem.188.12.2381. PMID 9858525. 
  39. ↑ "Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection". Nature Medicine 16 (4): 452–459. April 2010. doi:10.1038/nm.2106. PMID 20208540. 
  40. ↑ 40.0 40.1 "Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease". Immunological Reviews 245 (1): 227–238. January 2012. doi:10.1111/j.1600-065X.2011.01076.x. PMID 22168423. 
  41. ↑ "Pathogen-Induced TLR4-TRIF Innate Immune Signaling in Hematopoietic Stem Cells Promotes Proliferation but Reduces Competitive Fitness". Cell Stem Cell 21 (2): 225–240.e5. August 2017. doi:10.1016/j.stem.2017.06.013. PMID 28736216. 
  42. ↑ "The equine TLR4/MD-2 complex mediates recognition of lipopolysaccharide from Rhodobacter sphaeroides as an agonist". Journal of Endotoxin Research 13 (4): 235–242. 2007. doi:10.1177/0968051907083193. PMID 17956942. 
  43. ↑ "Does the shape of lipid A determine the interaction of LPS with Toll-like receptors?". Trends in Immunology 23 (3): 135–139. March 2002. doi:10.1016/S1471-4906(01)02169-X. PMID 11864841. 
  44. ↑ "Intrinsic conformation of lipid A is responsible for agonistic and antagonistic activity". European Journal of Biochemistry 267 (10): 3032–3039. May 2000. doi:10.1046/j.1432-1033.2000.01326.x. PMID 10806403. 
  45. ↑ "Genomic Organization of LPS-Specific Loci". Pathogenicity Islands and the Evolution of Pathogenic Microbes. Current Topics in Microbiology and Immunology. 2. 2002. pp. 109–35. doi:10.1007/978-3-642-56031-6_7. 264. ISBN 978-3-540-42682-0. 
  46. ↑ "Variation suggestive of horizontal gene transfer at a lipopolysaccharide (lps) biosynthetic locus in Xanthomonas oryzae pv. oryzae, the bacterial leaf blight pathogen of rice". BMC Microbiology 4: 40. October 2004. doi:10.1186/1471-2180-4-40. PMID 15473911. 
  47. ↑ 47.0 47.1 47.2 47.3 47.4 "The structure of lipooligosaccharide produced by Neisseria gonorrhoeae, strain 15253, isolated from a patient with disseminated infection. Evidence for a new glycosylation pathway of the gonococcal lipooligosaccharide". The Journal of Biological Chemistry 269 (48): 30345–30351. December 1994. doi:10.1016/S0021-9258(18)43819-7. PMID 7982947. 
  48. ↑ "Antigenic diversity of Haemophilus somnus lipooligosaccharide: phase-variable accessibility of the phosphorylcholine epitope". Journal of Clinical Microbiology 38 (12): 4412–4419. December 2000. doi:10.1128/JCM.38.12.4412-4419.2000. PMID 11101573. 
  49. ↑ "TRP Channels as Sensors of Bacterial Endotoxins". Toxins 10 (8): 326. August 2018. doi:10.3390/toxins10080326. PMID 30103489. 
  50. ↑ "TRPA1 channels mediate acute neurogenic inflammation and pain produced by bacterial endotoxins". Nature Communications 5: 3125. 20 January 2014. doi:10.1038/ncomms4125. PMID 24445575. Bibcode: 2014NatCo...5.3125M. 
  51. ↑ "Gustatory-mediated avoidance of bacterial lipopolysaccharides via TRPA1 activation in Drosophila". eLife 5. June 2016. doi:10.7554/eLife.13133. PMID 27296646. 
  52. ↑ "Differential effects of lipopolysaccharide on mouse sensory TRP channels". Cell Calcium 73: 72–81. July 2018. doi:10.1016/j.ceca.2018.04.004. PMID 29689522. 
  53. ↑ "TRPV4 activation triggers protective responses to bacterial lipopolysaccharides in airway epithelial cells". Nature Communications 8 (1): 1059. October 2017. doi:10.1038/s41467-017-01201-3. PMID 29057902. Bibcode: 2017NatCo...8.1059A. 
  54. ↑ 54.0 54.1 54.2 54.3 54.4 54.5 54.6 54.7 54.8 "The Role of Lipopolysaccharide-Induced Cell Signalling in Chronic Inflammation". Chronic Stress 6: 24705470221076390. 2022. doi:10.1177/24705470221076390. PMID 35155966. 
  55. ↑ "Endotoxins and other sepsis triggers". Endotoxemia and Endotoxin Shock. Contributions to Nephrology. 167. 2010. pp. 14–24. doi:10.1159/000315915. ISBN 978-3-8055-9484-4. 
  56. ↑ 56.0 56.1 "Metabolic endotoxemia and diabetes mellitus: A systematic review". Metabolism 68: 133–144. March 2017. doi:10.1016/j.metabol.2016.12.009. PMID 28183445. 
  57. ↑ 57.0 57.1 "Endotoxemia, nutrition, and cardiometabolic disorders". Acta Diabetologica 52 (2): 395–404. April 2015. doi:10.1007/s00592-014-0662-3. PMID 25326898. 
  58. ↑ "Genetic Profile of Endotoxemia Reveals an Association With Thromboembolism and Stroke". Journal of the American Heart Association 10 (21): e022482. November 2021. doi:10.1161/JAHA.121.022482. PMID 34668383. 
  59. ↑ "Acute alcoholic hepatitis". Journal of Clinical Gastroenterology 40 (9): 833–841. October 2006. doi:10.1097/01.mcg.0000225570.04773.5d. PMID 17016141. 
  60. ↑ "Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease". Journal of Hepatology 32 (5): 742–747. May 2000. doi:10.1016/S0168-8278(00)80242-1. PMID 10845660. 
  61. ↑ 61.0 61.1 61.2 "Epidemic meningitis, meningococcaemia, and Neisseria meningitidis". Lancet 369 (9580): 2196–2210. June 2007. doi:10.1016/S0140-6736(07)61016-2. PMID 17604802. 
  62. ↑ "Association of lipopolysaccharide-binding protein and coronary artery disease in men". Journal of the American College of Cardiology 50 (1): 25–31. July 2007. doi:10.1016/j.jacc.2007.02.070. PMID 17601541. 
  63. ↑ "Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis". Obesity Surgery 17 (10): 1374–1380. October 2007. doi:10.1007/s11695-007-9243-7. PMID 18000721. 
  64. ↑ 64.0 64.1 "Metabolic endotoxemia initiates obesity and insulin resistance". Diabetes 56 (7): 1761–1772. July 2007. doi:10.2337/db06-1491. PMID 17456850. 
  65. ↑ "An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice". The ISME Journal 7 (4): 880–884. April 2013. doi:10.1038/ismej.2012.153. PMID 23235292. Bibcode: 2013ISMEJ...7..880F. 
  66. ↑ "Bacterial lipopolysaccharide copurifies with plasmid DNA: implications for animal models and human gene therapy". Human Gene Therapy 6 (3): 317–323. March 1995. doi:10.1089/hum.1995.6.3-317. PMID 7779915. 
  67. ↑ "Endotoxin contamination of ovalbumin suppresses murine immunologic responses and development of airway hyper-reactivity". The Journal of Biological Chemistry 278 (43): 42361–42368. October 2003. doi:10.1074/jbc.M307752200. PMID 12909619. 
  68. ↑ "The Detection of Endotoxins Via the LAL Test, the Chromogenic Method". Wako Chemicals USA, Inc.. 16 December 2014. http://www.wakopyrostar.com/blog/post/the-detection-of-endotoxins-via-the-lal-test-the-chromogenic-method/. 
  69. ↑ "Biochemical principle of Limulus test for detecting bacterial endotoxins". Proceedings of the Japan Academy. Series B, Physical and Biological Sciences 83 (4): 110–119. May 2007. doi:10.2183/pjab.83.110. PMID 24019589. Bibcode: 2007PJAB...83..110I. 
  70. ↑ "A new era in pyrogen testing". Trends in Biotechnology 19 (8): 277–281. August 2001. doi:10.1016/s0167-7799(01)01694-8. PMID 11451451. http://www.horseshoecrab.org/research/sites/default/files/TIBTECH-rFC.pdf. Retrieved 2 January 2014. 

External links



Retrieved from "https://handwiki.org/wiki/index.php?title=Biology:Lipopolysaccharide&oldid=3564563"